Literature DB >> 26530927

Vitamin D status, body composition and glycemic control in an ambulatory population with diabetes and chronic kidney disease.

M R Hoffmann1, P A Senior2,3, S T Jackson1, K Jindal3,4,5, D R Mager1,6.   

Abstract

BACKGROUND/
OBJECTIVES: To determine the interrelationships between body composition, glycemic control and vitamin D status in an ambulatory population with diabetes (DM) and chronic kidney disease (CKD). SUBJECTS/
METHODS: Adult (18-80 years) patients (n=60) with DM and stage 1-4 CKD were recruited from the Northern Alberta Renal Program. Outcome variables included body composition (absolute/regional fat (FM)/lean soft tissue/total mass, percent fat/lean/fat-free (FFM) mass), glycemic control (glycated hemoglobin (HbA1c)), vitamin D intake (dietary/supplemental) and vitamin D status (25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D)) measured by validated methodologies. Sarcopenia was determined as an appendicular skeletal mass/height(2) less than 7.26 kg/m(2) (males) and 5.45 kg/m(2) (females).
RESULTS: Suboptimal HbA1c (>7%), 25(OH)D (<50 nmol/l) and 1,25(OH)2D (<43 pmol/l) concentrations were present in 57, 8 and 11% of participants. Ten percent of subjects had sarcopenia. Gender/age/DM type, not CKD, significantly influenced regional/whole body composition. Females, older participants and those with type 2 DM had higher %FM. No significant interrelationships between vitamin D status and glycemic control were observed (P>0.05). Serum 25(OH)D concentrations were inversely associated with arm lean soft tissue/FFM/total mass, weight, appendicular skeletal mass, lean soft tissue/height(2), FFM/height(2), appendicular skeletal mass/height(2) and body mass index (P<0.05). Sarcopenia occurred more frequently in patients with 25(OH)D concentrations ⩾100 nmol/l. Regional/whole body %FM was inversely related to 1,25(OH)2D, not 25(OH)D.
CONCLUSIONS: Body composition, not glycemic control, is associated with vitamin D status in an ambulatory population of adults with DM and CKD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26530927     DOI: 10.1038/ejcn.2015.185

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  51 in total

Review 1.  The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.

Authors:  Chantal Mathieu; Luciano Adorini
Journal:  Trends Mol Med       Date:  2002-04       Impact factor: 11.951

2.  Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the postmenopausal Health Study.

Authors:  George Moschonis; Sofia Tanagra; Konstantinos Koutsikas; Anna Nikolaidou; Odysseas Androutsos; Yannis Manios
Journal:  Menopause       Date:  2009 Jul-Aug       Impact factor: 2.953

3.  Redefining vitamin D insufficiency.

Authors:  A Malabanan; I E Veronikis; M F Holick
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

Review 4.  Obesity, metabolic syndrome and diabetic nephropathy.

Authors:  Christine Maric; John E Hall
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

5.  Excess deaths associated with underweight, overweight, and obesity.

Authors:  Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

Review 6.  Putting cardiovascular disease and vitamin D insufficiency into perspective.

Authors:  Armin Zittermann; Stefanie S Schleithoff; Reiner Koerfer
Journal:  Br J Nutr       Date:  2005-10       Impact factor: 3.718

7.  Vitamin D and Sarcopenia/Falls.

Authors:  Joan M Lappe; Neil Binkley
Journal:  J Clin Densitom       Date:  2015-06-06       Impact factor: 2.617

8.  Not a simple fat-soluble vitamin: Changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults.

Authors:  C Ding; V Parameswaran; L Blizzard; J Burgess; G Jones
Journal:  J Intern Med       Date:  2010-11       Impact factor: 8.989

9.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

10.  Unraveling the effects of 1,25OH2D3 on global gene expression in pancreatic islets.

Authors:  H Wolden-Kirk; L Overbergh; C Gysemans; K Brusgaard; N Naamane; L Van Lommel; F Schuit; D L Eizirik; H Christesen; C Mathieu
Journal:  J Steroid Biochem Mol Biol       Date:  2012-11-05       Impact factor: 4.292

View more
  5 in total

Review 1.  Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?

Authors:  Ozkan Gungor; Sena Ulu; Nuri Baris Hasbal; Stefan D Anker; Kamyar Kalantar-Zadeh
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-10-21       Impact factor: 12.910

2.  Diabetes, sarcopenia and chronic kidney disease; the Screening for CKD among Older People across Europe (SCOPE) study.

Authors:  Francesc Formiga; Rafael Moreno-González; Andrea Corsonello; Axel Carlsson; Johan Ärnlöv; Francesco Mattace-Raso; Tomasz Kostka; Christian Weingart; Regina Roller-Wirnsberger; Lisanne Tap; Agnieszka Guligowska; Cornel Sieber; Gerhard Wirnsberger; Rada Artzi-Medvedik; Ilan Yehoshua; Cinzia Giuli; Fabrizia Lattanzio; Xavier Corbella
Journal:  BMC Geriatr       Date:  2022-03-28       Impact factor: 3.921

3.  Dietary source of saturated fat and percentage body fat of patients with type 2 diabetes mellitus: A cross-sectional study.

Authors:  Camila Kümmel Duarte; Ana Luiza Teixeira Dos Santos; Claudia Kirst; Graziela da S Nunes; Karine de Franceschi; Mirela Jobim de Azevedo; Themis Zelmanovitz
Journal:  Food Sci Nutr       Date:  2018-11-15       Impact factor: 2.863

Review 4.  The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach.

Authors:  Charlotte Delrue; Reinhart Speeckaert; Joris R Delanghe; Marijn M Speeckaert
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

5.  Association between serum 25-hydroxyvitamin D and glycated hemoglobin levels in type 2 diabetes patients with chronic kidney disease.

Authors:  Lee Ling Lim; Yong Muh Ng; Pei San Kang; Soo Kun Lim
Journal:  J Diabetes Investig       Date:  2017-06-27       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.